Welcome to our dedicated page for FutureTech II Acquisition SEC filings (Ticker: FTII), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Tracking a technology-focused SPAC like FutureTech II Acquisition Corp. (FTII) means sifting through trust-account math, redemption deadlines, and warrant adjustments hidden deep inside SEC exhibits. If you have ever wondered, “How do I find the next extension vote date or confirm the cash per share before redemption?” this page solves that problem. Our platform turns every dense document—including the critical FutureTech II Acquisition proxy statement executive compensation and FutureTech II Acquisition 8-K material events explained—into clear, concise language.
Stock Titan’s AI reads each filing the moment it lands on EDGAR and produces plain-English takeaways. Need the FutureTech II Acquisition annual report 10-K simplified or the latest FutureTech II Acquisition quarterly earnings report 10-Q filing? They’re here with line-item summaries of trust balances and sponsor advances. Curious about sponsor activity? Receive real-time alerts for FutureTech II Acquisition Form 4 insider transactions real-time, including every FutureTech II Acquisition insider trading Form 4 transactions disclosure. You’ll also get highlighted sections on warrant terms, PIPE financing, and any S-4 merger registration—so understanding FutureTech II Acquisition SEC documents with AI becomes effortless.
Professionals use this page to compare redemption values, monitor FutureTech II Acquisition executive stock transactions Form 4, and evaluate dilution before a vote. AI-powered summaries show how each filing may impact a pending business combination, while historical downloads let you back-test SPAC arbitrage models. From FutureTech II Acquisition earnings report filing analysis to automatic red-flag detection in 8-Ks, every disclosure is organized, searchable, and always up to date—so you can focus on decision-making, not document hunting.
FutureTech II Acquisition Corp. (FTII) is asking the SEC to withdraw its earlier Form S-4 registration statement (File No. 333-285001) under Rule 477. The company no longer plans to complete its business combination in the manner described in that filing.
FutureTech II and Longevity Biomedical, Inc. amended their business combination agreement so that FutureTech II will merge into Longevity Biomedical Holdings, Corp. (PubCo), and Longevity Biomedical, Inc. will then merge into a PubCo subsidiary. PubCo, as the new parent company, has filed a separate Form S-4 (File No. 333-291481) to register the securities for this revised structure, so the prior registration will not be used.
The company also asks that fees paid for the withdrawn registration be credited for potential future use under Rule 457(p).
FutureTech II Acquisition Corp. (FTII) filed a Form 12b-25, notifying a late filing for its Quarterly Report on Form 10‑Q for the period ended September 30, 2025. The company says additional time is needed to prepare, review, and finalize the financial statements despite substantial progress to date.
The company also anticipates a significant change in results: it expects to report a net loss for the three months ended September 30, 2025, larger than the loss in the same quarter of 2024, and a net loss for the nine months ended September 30, 2025 compared to net income for the same period in 2024. Management attributes this shift primarily to a material decrease in investment income.
FutureTech II Acquisition Corp. (FTII) terminated six previously executed Zero Interest Convertible Notes effective November 8, 2025. The notes, issued to individual investors in April 2025, had an aggregate principal of $1,025,000 and were convertible into shares after the closing of the company’s initial business combination.
The notes carried no interest unless the September 30, 2025 maturity date was extended, in which case 5% per annum would apply from the maturity date. No monies were paid to the company by the investors under these notes. With the termination, the notes are of no further force and effect.
FAQ
What is the current stock price of FutureTech II Acquisition (FTII)?
What is the market cap of FutureTech II Acquisition (FTII)?
